Literature DB >> 9266348

The activity of dihydropyrimidine dehydrogenase in human blood cells.

A B Van Kuilenburg1, M J Blom, H Van Lenthe, E Mul, A H Van Gennip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9266348     DOI： 10.1023/a:1005305323052

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  8 in total

1.  Clinical and biochemical findings in six patients with pyrimidine degradation defects.

Authors:  A H van Gennip; N G Abeling; A E Stroomer; H van Lenthe; H D Bakker
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

2.  Catabolism of exogenously supplied thymidine to thymine and dihydrothymine by platelets in human peripheral blood.

Authors:  R W Pero; D Johnson; A Olsson
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

3.  Metabolic comparison between basophils and other leukocytes from human blood.

Authors:  M de Boer; D Roos
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

4.  Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency.

Authors:  J A Bakkeren; R A De Abreu; R C Sengers; F J Gabreëls; J M Maas; W O Renier
Journal:  Clin Chim Acta       Date:  1984-07-31       Impact factor: 3.786

5.  Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy.

Authors:  Z Lu; R Zhang; R B Diasio
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

6.  Enzymes of uracil catabolism in normal and neoplastic human tissues.

Authors:  F N Naguib; M H el Kouni; S Cha
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man.

Authors:  A B Van Kuilenburg; H Van Lenthe; A H Van Gennip
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

Review 8.  Clinical pharmacology of 5-fluorouracil.

Authors:  R B Diasio; B E Harris
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447
  8 in total
  3 in total

1.  Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation.

Authors:  A B van Kuilenburg; P Vreken; L V Beex; R A De Abreu; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

2.  Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.

Authors:  Jaap A Bakker; Patrick Schlesser; Hubert J M Smeets; Baudouin Francois; Jörgen Bierau
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

3.  Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time.

Authors:  Marieke J H Coenen; Aimée D C Paulussen; Marc Breuer; Martijn Lindhout; Demis C J Tserpelis; Anja Steyls; Jörgen Bierau; Bianca J C van den Bosch
Journal:  Curr Ther Res Clin Exp       Date:  2018-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.